Us TOO in Seattle

Prostate Cancer Education, Support and Advocacy

Us TOO in Seattle Prostate Cancer Support Group meetings are open to men with prostate cancer, their loved ones, friends, and caregivers. Our goal is to provide comprehensive information on prostate cancer, its diagnoses, treatments, side effects, current research and other aspects that may be used to help us make informed decisions about the disease. Us TOO in Seattle monthly meetings offer peer-to-peer interaction and support, plus unbiased information from experts in areas related to prostate cancer including surgery, radiation, medication, psychology, healthy lifestyles, and more.

Spouses, partners, other family members and caregivers are welcome.

 Each Us TOO in Seattle meeting starts at 6pm with a facilitated discussion between participants followed by an educational presentation at 7pm by a healthcare provider or other speaker.  Meetings end promptly at 8:00.

Next Meeting  

Wednesday, January 26, 2022, 6 -8 pm in person and online

Guest speaker: Howard Wollinski, 6:00 pm 

Subject: Active Surveillance, an Option for Newly Diagnosed Men

Howard Wolinski is a Chicago-based medical writer who specializes in prostate cancer information. He is a frequent contributor to MedPage Today, a board member of AnCan, and has been nominated twice for Pulitzer Prizes for articles published by the Chicago Sun-Times. His own prostate cancer diagnosis has led him to champion Active Surveillance as a strategy for timing the onset of treatment.  

Roundtable discussion among members and guests, 7:00 pm to 8:00 pm.

 

Join us via Zoom or in person at the Greenwood Senior Center, 525 N 85th Street, Seattle, WA  

 

Future Meetings: 

Wednesday, March 23, 2022: 6:00 p.m.   - Guest speaker and topic to be determined.

 

 

Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.
Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.
Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.

 

 

Upcoming Events

Wednesday, Jan 26 at 6:00 PM - 8:00 PM
Wednesday, Feb 23 at 6:00 PM - 8:00 PM
Wednesday, Mar 23 at 6:00 PM - 8:00 PM
Wednesday, Apr 27 at 6:00 PM - 8:00 PM